Cord Blood Banking Market to Witness Significant Rise in Revenue During 2021-2027

Cord blood banking market is driven by increasing prevalence of lethal diseases including cancer, lymphomas, leukemias, metabolic disorders, as well as certain disorders of the blood and immune systems. Cord blood samples are now frequently collected and stored worldwide, given that they are extensively rich in stem cells and are used as a treatment option for several of the diseases mentioned above.

The study which was done in the year between 1996-2001, revealed that patients ages between 16-60 with several cases of leukemia treated with stem cell transplantation. Similar studies supporting the importance of the treatment will undoubtedly fuel the expansion of the cord blood banking market in the coming years.

Request for a sample copy of this report @

Based on services, the global cord blood banking market from the storage services segment is poised to depict a CAGR of 5.6% through 2025, owing to increasing knowledge about the advantages of storing cord blood cells in private banks, coupled with rising government initiatives to encourage parents to donate cord blood cells of their newborn babies for treatment of various diseases.

Based on application, the cancer segment is projected to account for a major market share over the estimated timeline, which can be attributed to the escalating number of cancer patients worldwide, and effectiveness of cord blood cells in disease treatment. For example, the product finds widespread application in the treatment of non-Hodgkin’s leukemia and lymphoma.

With regards to the end-use spectrum, the hospitals segment is set to record remuneration worth $13.2 billion by 2025, which is attributable to the growing adoption of cord blood stem cells in treating genetic diseases. The segmental growth can further be credited to shifting preference of patients to the available treatments at hospitals, alongside rapid healthcare infrastructural advancements.

Spain cord blood banking market held a high market share in 2018 and is projected to register a $1,992.3 million revenue by 2025, due to rapid preservation of cord blood in private and public banks in the region. Additionally, the presence of enhanced cord-blood bank networks and government support towards raising awareness about the product benefits will considerably foster regional market dynamics in years to come.

Key cord blood banking market players include ViaCord LLC, Jeevan Stem Cell Foundation, LifeCell, Americord, Global Cord Blood Corporation, FamiCord, Cryo-Save AG, and CBR Systems, Inc., among others. These firms are focusing on gaining lucrative growth opportunities through various strategies such as R&D and business expansion.

Request for customization @

Partial Chapter of the Table of Content

Chapter 4.     Cord Blood Banking Market, By Type of Bank

4.1. Key segment trends

4.2. Public

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3. Private

4.3.1. Market size, by region, 2014 – 2025  (USD Million)

Chapter 5.     Cord Blood Banking Market, By Services

5.1. Key segment trends

5.2. Processing

5.2.1.  Market size, by region, 2014 – 2025 (USD Million)

5.3. Storage

5.3.1.  Market size, by region, 2014 – 2025 (USD Million)

5.4. Others

5.4.1.  Market size, by region, 2014 – 2025 (USD Million)

Chapter 6.     Cord Blood Banking Industry, By Application

6.1.  Key segment trends

6.2.  Cancer

6.2.1.    Market size, by region, 2014 – 2025 (USD Million)

6.3.  Blood Disorders

6.3.1.    Market size, by region, 2014 – 2025 (USD Million)

6.4.  Immuno-deficiency disorders

6.4.1.    Market size, by region, 2014 – 2025 (USD Million)

6.5.  Metabolic disorders

6.5.1.    Market size, by region, 2014 – 2025 (USD Million)

6.6.  Bone marrow failure syndrome

Browse full table of contents (TOC) of this report @